aXichem
2.07 SEK
-7.17 %
Less than 1K followers
AXIC A
First North Stockholm
Chemicals
Basic Materials
Overview
Financials & Estimates
Ownership
Investor consensus
-7.17 %
-20.08 %
-34.29 %
-28.37 %
+52.77 %
+55.06 %
-83.58 %
-95.86 %
-87.74 %
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.
Read moreMarket cap
122.37M SEK
Turnover
101.15K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
21/5
2026
Interim report Q1'26
17/6
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Västra Hamnen Market Focus: aXichem: Nytt avrop från Chr. Olesen
aXichem AB: aXichem genomför ännu en avropsleverans av aXiphen till Chr. Olesen i Brasilien inom ramen för tidigare order
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools